Objective
The QuIC-ConCePT consortium has 2 objectives:
1.(90% of resource, WP2-5) to qualify 3 specific imaging biomarkers (IBs) of tumour cell proliferation, apoptosis, and necrosis, to allow drug developers to demonstrate reliably modulation of these pathologic processes in tumours in patients in realistic trials. Our vision for January 2016 is that drug developers can incorporate these IBs for decision-making in Phase I trials of investigational therapies, confident that the IBs are technically valid, that a measured change in the IB faithfully reflects the desired change in the underlying tumour pathology, and that the IBs can be readily deployed in multiple cancer centres in a robust, consistent, ethical, and cost-effective way acceptable to patients.
2.(10% of resource, WP6) includes a portfolio of innovative approaches to devise, evaluate and introduce IBs of invasion and metastasis.
The IBs of tumour cell proliferation and necrosis will be developed respectively from FLT PET and ADC MRI respectively. Initial apoptosis plans focus on ICMT11 PET, possibly with other IBs introduced later. The project will be delivered using a portfolio of animal (WP2), human (WP3), image analysis (WP4) and regulatory (WP5) work. The project will be coordinated and the interdependent workpackages integrated in WP1. These WPs will deliver image acquisition and analysis protocols which are technically valid, standardised and suitable for multicentre use. We will evaluate reproducibility, effects of intervention, timing, dose-response, and imaging-histopathology correlation in animals and patients. The project is timely, and highly likely to deliver IBs which will markedly improve drug development, and benefit cancer patients in Europe and globally. The managing entity (EORTC) is already world-leading in the qualification of IBs, and the consortium includes in the academic and EFPIA partners some of the world's most productive and innovative physicians and scientists in cancer imaging.
Fields of science
Call for proposal
IMI-JU-02-2009
See other projects for this call
Coordinator
1200 Bruxelles / Brussel
Belgium
See on map
Participants (23)
151 85 Sodertaelje
See on map
Participation ended
E20 1JQ LONDON
See on map
M13 9PL Manchester
See on map
48149 MUENSTER
See on map
6525 XZ Nijmegen
See on map
75654 Paris
See on map
6229 ET Maastricht
See on map
1081 HV Amsterdam
See on map
WC2R 2LS London
See on map
2650 Edegem
See on map
SW7 3RP London
See on map
3015 GD Rotterdam
See on map
SW7 2AZ LONDON
See on map
44815 Saint-Herblain
See on map
8092 Zuerich
See on map
1831 Diegem
See on map
RG21 4FA Basingstoke
See on map
WC1A 1DG LONDON
See on map
64293 Darmstadt
See on map
CT13 9NJ Sandwich
See on map
4070 Basel
See on map
94250 GENTILLY
See on map
CB2 1TN Cambridge
See on map